Revision history of "Structured Program on Bioengineered Therapies for Infectious Diseases and Tissue Regeneration" (Q2888625)

Jump to navigation Jump to search

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

7 March 2024

14 November 2023

10 June 2023

23 May 2023

9 November 2022

29 July 2022

  • curprev 13:1613:16, 29 July 2022DG Regio talk contribs 43,910 bytes +26,717 Changed label, description and/or aliases in et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, da, ro, sv, nl, fr, de, it, pt, es, and other parts: Adding translations: et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, da, ro, sv,

20 January 2022

17 January 2022

19 December 2021

13 December 2021

5 December 2021

4 December 2021

21 October 2021

13 September 2021

8 July 2021

  • curprev 05:5105:51, 8 July 2021DG Regio talk contribs 9,438 bytes +1,230 Created claim: summary (P836): This Program aims to develop innovative anti-infectious, immunomodulatory and regenerative bioengineering therapeutic strategies through the approach of complex problems in infection, immunity and tissue regeneration, bringing together complementary research groups of i3S (Ineb, IBMC and FMUP) and CBQF (UCP/ESB) with a long history of collaboration and translation of research results for clinical benefit., translated_summary
  • curprev 05:5105:51, 8 July 2021DG Regio talk contribs 8,208 bytes −1,230 Removed claim: summary (P836): This Program aims to develop innovative anti-infectious, immunomodulatory and regenerative bioengineering therapeutic strategies through the approach of complex problems in infection, immunity and tissue regeneration, bringing together complementary research groups of i3S (Ineb, IBMC and FMUP) and CBQF (UCP/ESB) with a long history of collaboration and translation of research results for clinical benefit., remove_old_english_translation
  • curprev 05:5005:50, 8 July 2021DG Regio talk contribs 9,438 bytes +1,230 Created claim: summary (P836): This Program aims to develop innovative anti-infectious, immunomodulatory and regenerative bioengineering therapeutic strategies through the approach of complex problems in infection, immunity and tissue regeneration, bringing together complementary research groups of i3S (Ineb, IBMC and FMUP) and CBQF (UCP/ESB) with a long history of collaboration and translation of research results for clinical benefit., translated_summary

7 July 2021

6 July 2021